Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

Lux F, Tran VL, Thomas E, Dufort S, Rossetti F, Martini M, Truillet C, Doussineau T, Bort G, Denat F, Boschetti F, Angelovski G, Detappe A, Crémillieux Y, Mignet N, Doan BT, Larrat B, Meriaux S, Barbier E, Roux S, Fries P, Müller A, Abadjian MC, Anderson C, Canet-Soulas E, Bouziotis P, Barberi-Heyob M, Frochot C, Verry C, Balosso J, Evans M, Sidi-Boumedine J, Janier M, Butterworth K, McMahon S, Prise K, Aloy MT, Ardail D, Rodriguez-Lafrasse C, Porcel E, Lacombe S, Berbeco R, Allouch A, Perfettini JL, Chargari C, Deutsch E, Le Duc G, Tillement O.

Br J Radiol. 2018 Sep 18:20180365. doi: 10.1259/bjr.20180365. [Epub ahead of print]

PMID:
30226413
2.

A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.

Tsoukalas C, Psimadas D, Kastis GA, Koutoulidis V, Harris AL, Paravatou-Petsotas M, Karageorgou M, Furenlid LR, Moulopoulos LA, Stamopoulos D, Bouziotis P.

Front Chem. 2018 Jun 20;6:224. doi: 10.3389/fchem.2018.00224. eCollection 2018.

3.

Recommendations for In Vitro and In Vivo Testing of Magnetic Nanoparticle Hyperthermia Combined with Radiation Therapy.

Spirou SV, Costa Lima SA, Bouziotis P, Vranješ-Djurić S, Efthimiadou EΚ, Laurenzana A, Barbosa AI, Garcia-Alonso I, Jones C, Jankovic D, Gobbo OL.

Nanomaterials (Basel). 2018 May 6;8(5). pii: E306. doi: 10.3390/nano8050306. Review.

4.

Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.

Tsoukalas C, Geninatti-Crich S, Gaitanis A, Tsotakos T, Paravatou-Petsotas M, Aime S, Jiménez-Juárez R, Anagnostopoulos CD, Djanashvili K, Bouziotis P.

Mol Imaging Biol. 2018 Oct;20(5):798-807. doi: 10.1007/s11307-018-1176-0.

PMID:
29464496
5.

Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.

Karageorgou MA, Vranješ-Djurić S, Radović M, Lyberopoulou A, Antić B, Rouchota M, Gazouli M, Loudos G, Xanthopoulos S, Sideratou Z, Stamopoulos D, Bouziotis P, Tsoukalas C.

Contrast Media Mol Imaging. 2017 Dec 28;2017:6951240. doi: 10.1155/2017/6951240. eCollection 2017.

6.

Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study.

Papachristou M, Kastis GA, Stavrou PZ, Xanthopoulos S, Furenlid LR, Datseris IE, Bouziotis P.

Mol Med Rep. 2018 Feb;17(2):2442-2448. doi: 10.3892/mmr.2017.8166. Epub 2017 Nov 27.

7.

68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.

Bouziotis P, Stellas D, Thomas E, Truillet C, Tsoukalas C, Lux F, Tsotakos T, Xanthopoulos S, Paravatou-Petsotas M, Gaitanis A, Moulopoulos LA, Koutoulidis V, Anagnostopoulos CD, Tillement O.

Nanomedicine (Lond). 2017 Jul;12(13):1561-1574. doi: 10.2217/nnm-2017-0032. Epub 2017 Jun 16.

8.

Investigation of Image Reconstruction Parameters of the Mediso nanoScan PC Small-Animal PET/CT Scanner for Two Different Positron Emitters Under NEMA NU 4-2008 Standards.

Gaitanis A, Kastis GA, Vlastou E, Bouziotis P, Verginis P, Anagnostopoulos CD.

Mol Imaging Biol. 2017 Aug;19(4):550-559. doi: 10.1007/s11307-016-1035-9.

PMID:
27995432
9.

Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study.

Radchenko V, Bouziotis P, Tsotakos T, Paravatou-Petsotas M, la Fuente Ad, Loudos G, Harris AL, Xanthopoulos S, Filosofov D, Hauser H, Eisenhut M, Ponsard B, Roesch F.

Nucl Med Biol. 2016 May;43(5):280-7. doi: 10.1016/j.nucmedbio.2016.02.003. Epub 2016 Feb 14.

PMID:
27150030
10.

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging.

Tsoukalas C, Laurent G, Jiménez Sánchez G, Tsotakos T, Bazzi R, Stellas D, Anagnostopoulos C, Moulopoulos L, Koutoulidis V, Paravatou-Petsotas M, Xanthopoulos S, Roux S, Bouziotis P.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A89. doi: 10.1186/2197-7364-2-S1-A89. No abstract available.

11.

Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.

Lyberopoulou A, Aravantinos G, Efstathopoulos EP, Nikiteas N, Bouziotis P, Isaakidou A, Papalois A, Marinos E, Gazouli M.

PLoS One. 2015 Apr 22;10(4):e0123902. doi: 10.1371/journal.pone.0123902. eCollection 2015.

12.

High resolution MR eye protocol optimization: Comparison between 3D-CISS, 3D-PSIF and 3D-VIBE sequences.

Tsiapa I, Tsilimbaris MK, Papadaki E, Bouziotis P, Pallikaris IG, Karantanas AH, Maris TG.

Phys Med. 2015 Nov;31(7):774-80. doi: 10.1016/j.ejmp.2015.03.009. Epub 2015 Apr 11.

PMID:
25869179
13.

Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.

Truillet C, Bouziotis P, Tsoukalas C, Brugière J, Martini M, Sancey L, Brichart T, Denat F, Boschetti F, Darbost U, Bonnamour I, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Perriat P, Lux F, Tillement O.

Contrast Media Mol Imaging. 2015 Jul-Aug;10(4):309-19. doi: 10.1002/cmmi.1633. Epub 2014 Dec 5.

PMID:
25483609
14.

Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC.

Cancer Biother Radiopharm. 2014 Dec;29(10):444-50. doi: 10.1089/cbr.2014.1672.

15.

Quantum dots-bevacizumab complexes for in vivo imaging of tumors.

Gazouli M, Bouziotis P, Lyberopoulou A, Ikonomopoulos J, Papalois A, Anagnou NP, Efstathopoulos EP.

In Vivo. 2014 Nov-Dec;28(6):1091-5.

PMID:
25398804
16.

(99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.

Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, Kordas GC, Mihailidis D, Nikiforidis GC, Xanthopoulos S, Psimadas D, Paravatou-Petsotas M, Palamaris L, Hazle JD, Kagadis GC.

J Colloid Interface Sci. 2014 Nov 1;433:163-175. doi: 10.1016/j.jcis.2014.07.032. Epub 2014 Aug 1.

PMID:
25128864
17.

Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection.

Truillet C, Bouziotis P, Tsoukalas C, Sancey L, Denat F, Boschetti F, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Lux F, Perriat P, Tillement O.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A80. doi: 10.1186/2197-7364-1-S1-A80. No abstract available.

18.

Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel ⁹⁹mTc(I)(CO)₃ labeled liposome.

Fragogeorgi EA, Savina IN, Tsotakos T, Efthimiadou E, Xanthopoulos S, Palamaris L, Psimadas D, Bouziotis P, Kordas G, Mikhalovsky S, Alavijeh M, Loudos G.

Int J Pharm. 2014 Apr 25;465(1-2):333-46. doi: 10.1016/j.ijpharm.2014.01.042. Epub 2014 Feb 26.

PMID:
24583207
19.

Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core.

Bouziotis P, Gourni E, Patsis G, Psimadas D, Zikos C, Fani M, Xanthopoulos S, Loudos G, Paravatou-Petsotas M, Livaniou E, Varvarigou AD, Pirmettis I, Papadopoulos M.

Bioorg Med Chem. 2013 Nov 1;21(21):6699-707. doi: 10.1016/j.bmc.2013.08.010. Epub 2013 Aug 12.

PMID:
24035515
20.

Radiolabeling approaches of nanoparticles with (99m) Tc.

Psimadas D, Bouziotis P, Georgoulias P, Valotassiou V, Tsotakos T, Loudos G.

Contrast Media Mol Imaging. 2013 Jul-Aug;8(4):333-9. doi: 10.1002/cmmi.1530. Review.

PMID:
23613436

Supplemental Content

Loading ...
Support Center